7 Useful App Features For Pharmaceutical & Biotechnology Conventions

MARIA SANDJAJA | March 21, 2014

article image
With an increasing shift towards environmental awareness and the norm of mobile technology users among these health experts, many pharma and medical meeting planners are shifting their contents digitally to eliminate the use of paper.

Spotlight

PHOENIX All-in-One

All-in-One: Our expertise and coverage for the success of manufacturer partners to provide manufacturer partners a unified approach to the European and all 26 local markets, the PHOENIX group has brought the service brand “All-in-One” into life. All-in-One grants a direct access for manufacturers to patients. With its eight focus areas from a Pan-European Preferred Partnerships, Healthcare Logistics, Business Intelligence, Patient Services to Supply Chain Optimization, Sales Support, Clinical Trial Supply Services and Services for Specialty Drugs, All-in-One has an unparalleled service to manufacturer partners throughout Europe. You do your core business – we care about the rest Our full-service offering enables manufacturers to focus on their core competencies – developing and successfully commercializing innovative products and solutions. We care about the rest. “All-in-One is more than just a collection of services, it is a unified approach to patients all over Europe”, says Stefan

OTHER ARTICLES

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | April 3, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | April 3, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | April 3, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 3, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Spotlight

PHOENIX All-in-One

All-in-One: Our expertise and coverage for the success of manufacturer partners to provide manufacturer partners a unified approach to the European and all 26 local markets, the PHOENIX group has brought the service brand “All-in-One” into life. All-in-One grants a direct access for manufacturers to patients. With its eight focus areas from a Pan-European Preferred Partnerships, Healthcare Logistics, Business Intelligence, Patient Services to Supply Chain Optimization, Sales Support, Clinical Trial Supply Services and Services for Specialty Drugs, All-in-One has an unparalleled service to manufacturer partners throughout Europe. You do your core business – we care about the rest Our full-service offering enables manufacturers to focus on their core competencies – developing and successfully commercializing innovative products and solutions. We care about the rest. “All-in-One is more than just a collection of services, it is a unified approach to patients all over Europe”, says Stefan

Events